The chairman and CEO of the Genzyme Corporation, one the country's top five biotechnology firms, has received a phone call requesting a meeting with the cofounder and principal of a large hedge fund that now has a 2.6% stake in his company. Before meeting with him, the CEO is aware that he needs a strategy for dealing with this "activist" investor with a track record of forcing out CEOs.

【書誌情報】

ページ数：25ページ

サイズ：A4

商品番号：HBSP-UV6529

発行日：2011/12/2

登録日：2013/7/8